AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: GOVX
Report Date: 2026-05-21
Full Report: https://amaly.io/stock/GOVX

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: GOVX, a biotechnology company focused on vaccine development, exhibits strong compliance in debt and non-permissible income ratios but fails liquidity thresholds across major standards, leading to non-compliance in Shariah indexes. Business activities in healthcare R&D are permissible, with low ESG risks. Overall, the stock is classified as non-compliant due to zero index inclusions, though regional variations exist. Purification is required at 3.84% for interest income. Investors should monitor financial improvements for potential future compliance.

Primary Compliance Concerns:
- Liquidity ratio exceeds 30-33% thresholds across AAOIFI, MSCI, and S&P standards
- High cash holdings relative to market cap may indicate interest-bearing assets

Purification Requirement: 3.84%
Index Inclusion: Not included in any major Shariah-compliant indexes

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 50.2%
Interest Income Ratio: 3.8%
Purification Required: 3.84%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-12-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-14T12:00:00Z

---
Full interactive report: https://amaly.io/stock/GOVX
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.